课题基金 / 基金详情

MECHANISM OF ACTION OF CYTOTOXIC NECROTIZING FACTOR(CNF)PRODUCED BY PATHOGENIC ESCHERICHIA COLI

MECHANISM OF ACTION OF CYTOTOXIC NECROTIZING FACTOR(CNF)PRODUCED BY PATHOGENIC ESCHERICHIA COLI
致病性大肠杆菌产生的细胞毒性坏死因子(CNF)的作用机制
批准号:
09670282
负责人:
SUGAI Motoyuki
金额:
$1.92万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1997
资助国家:
日本
项目状态:
已结题
起止时间:
1997 至 1998

项目摘要

项目成果

SUGAI Motoyuki的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The aim of this project was to undcrstand the molccular mcchanism how the cytotoxic necrotizing factor (CNF) produced by pathogccin Eschcrichia coli activate small (G-protein Rho and its relatcd families in culture cells. We utilized E.coli coexpression system to know the effect of the toxin on the small GTPascs. Therefore we gencrated E.coli carrying cnf2 and cDNA of rhoA, cdc42, or rac1. Since these GTPases possesed FLAG-Lag at thte N-terminal, they could be purified by using Sepharose beads with monoclonal antibody against FLAG-tag as ligand. Accordingly we purified CNF-modificd and -unmodified small GTPascs, and measured their intrinsic GTPasc activity, CAP (GTPase activating protein) stimulated GTPase activity, GTPrS binding activity. The data indicated that CNF2 inhibited GTPase activity of RhoA and Rac1. On the other hand, CNF1 inhiibited GTPasc activity of RhoA and Cdc42. Analysis of overproduced RhoA modified by CNF2 indicated that CNF2 deamidated RhoA at 63rd Q and converted it to U.We also used polyclonal antibody raised against Switch H domain of Rho family GTPascs with substitution of 63rd (or 61st) Q as E.This antibody presumably recognizes CNF-modificd small GTPascs. As expected. Western analysis of CNF2-modificd small GTPascs revealed that RhoA and Racl were immunolabeled with this antibody but not was Cdc42. On the other hand, Western analysis of CNF1-modified small GTPascs showed that RhoA and Cdc42 were positive while Raci was negative. These results clearly indicated that CNF2 possess deamidase activity like CNF1. but their substrate specificitics arc distinct.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
最上 享: "肥満細胞からのヒスタミン開口放出を制御するG蛋白質の研究:Rhoの役割" Ther.Res.18. 58-63 (1997)
Toru Mogami:“控制肥大细胞组胺胞吐作用的 G 蛋白的研究:Rho 的作用”Ther.Res.18 (1997)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
菅井 基行: "低分子量G蛋白質を標的とする細菌毒素" 化学と生物. 36(7). 428-435 (1998)
Motoyuki Sugai:“针对低分子量 G 蛋白的细菌毒素”化学与生物学 36(7) (1998)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Mogami, A., Hide, I., Sugai, M., Shigemoto, Y., Hatazaki, K., Suginaka, H., Nakata, Y.: "Studies on small G proteins regulating histamin release from Mast cells in Japanese" Ther.Res.19. 161-165
Mogami, A.、Hide, I.、Sugai, M.、Shigemoto, Y.、Hatazaki, K.、Suginaka, H.、Nakata, Y.:“调节日本肥大细胞组胺释放的小 G 蛋白的研究”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Sugai, M., Mogami, A., Hatazaki, K.: "Bacterial toxins targeting small G proteins (in Japanese)" Kagaku to Seibutsu. 36(7). 428-435 (1998)
Sugai, M.、Mogami, A.、Hatazaki, K.:“针对小 G 蛋白的细菌毒素(日语)” Kagaku to Seibutsu。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
18
    Intranuclear action of Cell cycle-specific growth inhibitory factor, CDT
    • 批准号:
      20592140
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.0万
    • 财政年份:
      2008
    • 负责人:
      SUGAI Motoyuki
    • 依托单位:
    Integrated Research on pathogenic factors of periodontal pathogens
    • 批准号:
      17591912
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.24万
    • 财政年份:
      2005
    • 负责人:
      SUGAI Motoyuki
    • 依托单位:
    Genome-wide study on pathogenesis of bacteria causing nosocomial infection
    • 批准号:
      17019048
    • 项目类别:
      Grant-in-Aid for Scientific Research on Priority Areas
    • 资助金额:
      $62.4万
    • 财政年份:
      2005
    • 负责人:
      SUGAI Motoyuki
    • 依托单位:
    Genomics and post-genomics of Staphylococcus aureus causing bullous impetigo
    • 批准号:
      15390143
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $8.51万
    • 财政年份:
      2003
    • 负责人:
      SUGAI Motoyuki
    • 依托单位:
    海外基金